Piramal Critical Care Inc

Piramal Critical Care Inc. is a company based in Bethlehem, Pennsylvania, operating as a business division of Piramal Pharma Limited. With 158 employees, the company generates an annual revenue of $100 million. Piramal Critical Care specializes in the development and manufacturing of a wide range of pharmaceutical products. Their portfolio includes inhalation anesthetics, intrathecal therapies for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapies for Type I Gaucher and Niemann Pick Type C disease, anticholinergics, plasma volume expanders, non-depolarizing neuromuscular blocking agents, depolarizing skeletal muscle relaxants, and anxiolytic, sedative, and pain medications. These products are designed for use in critical care settings and are distributed to healthcare providers worldwide. The company prides itself on its strong manufacturing and process development capabilities. Piramal Critical Care operates fully owned manufacturing facilities in Bethlehem, Pennsylvania, and Digwal, India, ensuring a robust supply chain and quality control. Customer-centricity is a core principle, reflected in their commitment to providing high-quality products and services. For any adverse effects related to their products, customers are encouraged to report them to [email protected].